The deadline for least-developed countries to protect pharmaceutical patents was revised in June 2002. This was followed by the waiver in August 2003, which itself called for the eventual amendment.
The decision directly transforms the Aug 30, 2003, 'waiver' into a permanent amendment of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS)," the statement said.
Article 31(f) of the TRIPS Agreement says that production under compulsory licensing must be predominantly for the domestic market.Hong Kong, Israel, Korea, Kuwait, Macao China, Mexico, Qatar, Singapore, Chinese Taipei, Turkey and United Arab Emirates have separately announced that if they use the amendment of the IPR system as importers it would only be for emergencies or extremely urgent situations."
Read more here.